It is unclear whether immunosuppression is a risk factor for herpes encephalitis. Herein, we describe a rare case of herpes simplex virus type 2 encephalitis in a patient treated with low-dose methotrexate for HLA-B27-associated spondyloarthritis. The patient was successfully treated with acyclovir but presented sequelae of encephalitis. Here we discuss the possible role of low-dose methotrexate therapy as a risk factor of neurological herpes reactivation and severe disease. The host-related and viral risk factors are also addressed.
References
1.
BergerJ.R., HouffS.Neurological complications of herpes simplex virus type 2 infection.Arch Neurol2008; 65: 596–600.
2.
MoonS.M., KimT., LeeE.M., KangJ.K., LeeS.A., ChoiS.H.Comparison of clinical manifestations, outcomes and cerebrospinal fluid findings between herpes simplex type 1 and type 2 central nervous system infections in adults.J Med Virol2014; 86: 1766–1771.
3.
OmlandL.H., VestergaardB.F., WandallJ.H.Herpes simplex virus type 2 infections of the central nervous system: a retrospective study of 49 patients.Scand J Infect Dis2008; 40: 59–62.
4.
GraberJ.J., RosenblumM.K., DeAngelisL.M.Herpes simplex encephalitis in patients with cancer.J Neurooncol2011; 105: 415–421.
5.
TanI.L., McArthurJ.C., VenkatesanA., NathA.Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised.Neurology2012; 79: 2125–2132.
6.
AglasF., RainerF., HermannJ.Interstitial pneumonia due to cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis.Arthritis Rheum1995; 38: 291–292.
7.
LyonC.C., ThompsonD.Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis.J Rheumatol1997; 24: 589–591.
8.
NardisC., AnzivinoE., BellizziA.Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: preliminary results.J Cell Physiol2012; 227: 3796–3802.
9.
HatachiS., KunitomiA., AozasaK., YagitaM.CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.Mod Rheumatol2010; 20: 500–505.
10.
VenkatesanA., TunkelA.R., BlochK.C.Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.Clin Infect Dis2013; 57: 1114–1128.
11.
Neumann-HaefelinC.HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?Curr Opin Rheumatol2013; 25: 426–433.
12.
Lekstrom-HimesJ.A., HohmanP., WarrenT.Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections.J Infect Dis1999; 179: 1077–1085.
13.
GerardsA.H., de LathouderS., de GrootE.R., DijkmansB.A., AardenL.A.Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.Rheumatology (Oxford)2003; 42: 1189–1196.
14.
LewandowskiG., HobbsM., GellerA.Evidence that deficient IFN-gamma production is a biological basis of herpes simplex virus type-2 neurovirulence.J Neuroimmunol1998; 81: 66–75.
15.
LafailleF.G., PessachI.M., ZhangS.Y.Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells.Nature2012; 491: 769–773.
16.
BradfordR.D., PettitA.C., WrightP.W.Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.Clin Infect Dis2009; 49: 924–927.
17.
ErdemH., CagY., Ozturk-EnginD.Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis.Antimicrob Agents Chemother2015; 59: 3084–3089.
18.
MarteliusT., LappalainenM., PalomakiM., AnttilaV.J.Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid.BMC Infect Dis2011; 11: 281.
19.
TangJ.W., LinM., ChiuL., KoayE.S.Viral loads of herpes simplex virus in clinical samples–a 5-year retrospective analysis.J Med Virol2010; 82: 1911–1916.
20.
Franzen-RöhlE., Tiveljung-LindellA., GrillnerL., AureliusE.Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples.J Clin Microbiol2007; 45: 2516–2520.
21.
Fernandez-GerlingerM., GreffeS., MeffreA.HSV-2 meningoencephalitis in an immunocompetent young man: what is the pathogenesis and what is the treatment?J Clin Virol2015; 69: 40–43.
22.
BarkerK.R., Sarafino-WaniR., KhanomA., GriffithsP.D., JacobsM.G., WebsterD P.Encephalitis in an immunocompetent man.J Clin Virol2014; 59: 1–3.
23.
KristinssonS.Y., TangM., PfeifferR.M.Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.Haematologica2012; 97: 854–858.
24.
JeanC.M., HonarmandS., LouieJ.K., GlaserC.A.Risk factors for West Nile virus neuroinvasive disease, California, 2005.Emerg Infect Dis2007; 13: 1918–1920.
